LYNDSIE LUJAN: Open Payments
NPI 1285268284 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 51 payments from 11 companies in 2025. Trend: 2023 $1,337 · 2024 $1,174 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $230 |
| Merck Sharp & Dohme LLC | 8 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $84 |
| PFIZER INC. | 3 | $66 |
| Novo Nordisk Inc | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| United Therapeutics Corporation | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
Products named: LEQVIO, VERQUVO, Kerendia, LifeVest, ELIQUIS, Wegovy, JARDIANCE, Tyvaso.
Industry payments across IA — which companies pay providers there.
